A
Alto Neuroscience, Inc. (ANRO)
NYQ – Real vaqt narxi. Valyuta: USD
24.63
+0.10 (0.41%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NYQ – Real vaqt narxi. Valyuta: USD
24.63
+0.10 (0.41%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Alto Neuroscience, Inc. Amerika Qo'shma Shtatlarida klinik bosqichdagi biofarmatsevtika kompaniyasi sifatida faoliyat yuritadi. Kompaniyaning mahsulotlar qatoriga bipolyar depressiya (BD) bilan og'rigan bemorlarni davolash uchun 2b bosqichli klinik sinovdan o'tayotgan ALTO-100 kiradi. Kompaniya, shuningdek, katta depressiv buzilish (KDB) bilan og'rigan bemorlarni davolash uchun 2b bosqichli klinik sinovdan o'tayotgan, antidepressant xususiyatlarga ega bo'lgan kichik molekulali melatonergik agonist va serotonergik antagonist ALTO-300; shizofreniya bilan bog'liq kognitiv buzilishlarni davolash uchun 2 bosqichli POC sinovidan o'tayotgan yangi kichik molekulali fosfodiesteraza 4 ingibitori ALTO-101; KDB va anhedoniya darajasi yuqori bo'lgan bemorlarni davolash uchun 2 bosqichli POC sinovidan o'tayotgan yangi kichik molekulali gistamin H3 retseptorining teskari agonisti ALTO-203; KDBni davolash uchun 1 bosqichli klinik sinovdan o'tayotgan NMDA retseptorining GluN2B subbirligining tadqiq qilinayotgan og'iz orqali yuboriladigan antagonist ALTO-202; va Parkinson kasalligi bilan og'rigan bemorlar uchun pramipexol va aprepitant, ko'ngil aynishiga qarshi vosita, neyrokinin-1 (NK-1) retseptorining antagonistining doimiy dozali kombinatsiyasi ALTO-208ni ishlab chiqadi. Kompaniya 2019 yilda ro'yxatga olingan va uning shtab-kvartirasi Mountain View, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Amit Etkin M.D., Ph.D. | Founder, Chairman of the Board, CEO & President |
| Mr. Adam Savitz M.D., Ph.D. | Chief Medical Officer |
| Mr. Dan Segal B.Sc. (Hons), BCom, CA, MSc | Co-Founder & Strategic Advisor |
| Mr. Michael C. Hanley M.B.A. | Chief Operating Officer |
| Mr. Nicholas C. Smith | CFO & Chief Business Officer |
| Ms. Erin R. McQuade J.D. | General Counsel, Chief Administrative Officer & Corporate Secretary |
| Ms. Jessica Powell | Chief Development Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-10 | S-3 | tm2611320-1_s3.htm |
| 2026-04-01 | 8-K | tm2610746d1_8k.htm |
| 2026-03-26 | DEFA14A | tm264616d3_defa14a.htm |
| 2026-03-16 | 8-K | alto-20260316.htm |
| 2026-03-16 | 10-K | alto-20251231.htm |
| 2025-12-08 | CORRESP | filename1.htm |
| 2025-11-28 | S-3 | tm2531771-1_s3.htm |
| 2025-11-12 | 10-Q | alto-20250930.htm |
| 2025-10-27 | D | |
| 2025-10-20 | 8-K | tm2529007d1_8k.htm |